1.
Nielsen C, Bojesen SE, Nordestgaard BG, Kofoed KF, Birgens HS. JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate. Haematologica [Internet]. 2014Aug.31 [cited 2026Nov.11];99(9):1448-55. Available from: https://haematologica.org/article/view/7137